TRAVERE THERAPEUTICS

travere-therapeutics-logo

Travere Therapeutics is advancing therapeutic candidates for rare disorders in nephrology, hepatology and metabolism; sponsoring no-cost genetic testing aimed at improving the diagnostic odyssey for children born with cholestasis; partnering with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access and education for its FDA-approved therapies.

#SimilarOrganizations #People #Financial #Event #Website #More

TRAVERE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2008-02-07

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.travere.com

Total Employee:
101+

Status:
Active

Contact:
(646) 564-3680

Email Addresses:
[email protected]

Total Funding:
942 M USD

Technology used in webpage:
Apple Mobile Web Clips Icon WordPress LetsEncrypt Amazon SSL By Default Mobile Non Scaleable Content IPv6 ReCAPTCHA Google Wordpress Plugins


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

arrepath-logo

ArrePath

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

f2g-logo

F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.


Current Advisors List

jeffrey-a-meckler_image

Jeffrey A. Meckler Chairman & Member of the Board of Directors @ Travere Therapeutics
Board_member
2014-01-01

suzanne-l-bruhn_image

Suzanne L. Bruhn Board Member @ Travere Therapeutics
Board_member
2020-04-01

ron-squarer_image

Ron Squarer Member Board Of Directors @ Travere Therapeutics
Board_member
2017-04-01

Current Employees Featured

not_available_image

William E. Rote
William E. Rote Senior VP of Research and Development @ Travere Therapeutics
Senior VP of Research and Development
2017-02-01

laura-clague_image

Laura Clague
Laura Clague Chief Financial Officer @ Travere Therapeutics
Chief Financial Officer
2014-11-01

stewart-bieler_image

Stewart Bieler
Stewart Bieler Vice President Clinical Operations @ Travere Therapeutics
Vice President Clinical Operations
2019-09-01

john-f-wood_image

John F. Wood
John F. Wood Vice President, Regulatory Affairs @ Travere Therapeutics
Vice President, Regulatory Affairs
2020-11-01

edwin-urrutia_image

Edwin Urrutia
Edwin Urrutia Vice President @ Travere Therapeutics
Vice President
2013-11-01

renato-ray-ramos_image

Renato โ€œRayโ€ Ramos
Renato โ€œRayโ€ Ramos Director of Supply Chain and Procurement @ Travere Therapeutics
Director of Supply Chain and Procurement
2017-07-01

noah-rosenberg_image

Noah Rosenberg
Noah Rosenberg Chief Medical Officer @ Travere Therapeutics
Chief Medical Officer
2018-07-01

ian-paterson_image

Ian Paterson
Ian Paterson Senior Director, Global Marketing @ Travere Therapeutics
Senior Director, Global Marketing
2019-08-01

eric-dube_image

Eric Dube
Eric Dube President & Chief Executive Officer @ Travere Therapeutics
President & Chief Executive Officer
2019-01-01

jula-inrig_image

Jula Inrig
Jula Inrig Chief Medical Officer @ Travere Therapeutics
Chief Medical Officer
2022-01-01

Founder


martin-shkreli_image

Martin Shkreli

Stock Details


Company's stock symbol is NASDAQ:TVTX

Acquisitions List

Date Company Article Price
2020-10-22 Orphan Technologies Orphan Technologies acquired by Travere Therapeutics 517 M USD
2014-02-13 Manchester Pharmaceuticals Manchester Pharmaceuticals acquired by Travere Therapeutics N/A

Investors List

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - Travere Therapeutics

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Equity - Travere Therapeutics

Investments List

Date Company Article Money raised
2014-07-31 Perlara Travere Therapeutics investment in Seed Round - Perlara 2.8 M USD

Key Employee Changes

Date New article
2022-01-04 Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer

Official Site Inspections

http://www.travere.com Semrush global rank: 1.58 M Semrush visits lastest month: 15.02 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Travere Therapeutics"

Who We Are | Travere

See details»

Careers | Travere Therapeutics

Travere employees work cross-functionally, collaborating with colleagues throughout the organization, and serve on committees such as our internal diversity council.See details»

Home - Travere Medical Affairs

Welcome to Travere Therapeutics Global Medical Affairs At Travere Therapeutics Global Medical Affairs, we are dedicated to sharing โ€ฆSee details»

Travere Therapeutics - Investor Relations

At Travere Therapeutics, we are in rare for life We come together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease.See details»

Travere Therapeutics - Events & Presentations

Travere Therapeutics First Quarter 2025 Earnings Results Investor Fact Sheet Open Event Link, PDF file, May 1, 2025, (opens in new window) Travere Therapeutics Fourth Quarter and Full Year 2024 Earnings ResultsSee details»

Travere Therapeutics - News

Jul 11, 2025 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) View PDF , Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4), June 12, 2025, (opens in new window) June 11, 2025 Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte ConferenceSee details»

Travere Therapeutics - LinkedIn

Travere Therapeutics | 35,794 followers on LinkedIn. In rare for life. | Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife ...See details»

Travere TotalCare - Support for Patient and โ€ฆ

Travere TotalCare provides patients and Healthcare Professionals with information on insurance coverage, financial assistance programs, โ€ฆSee details»

Travere Therapeutics Management Team | Org Chart - RocketReach

Travere Therapeutics employs 436 employees. The Travere Therapeutics management team includes Eric Dube (CEO), Angela Giannantonio (Chief People Officer), and Elizabeth Reed (Senior Vice President, General Counsel and Secretary).See details»

Log In - travereevents.com

Travere Therapeutics employee? Log in hereForgot your password? Set a new oneSee details»

Medical Information - Travere Medical Affairs

About Medical Information at Travere This site is an online medical resource that provides access to scientific, clinical, and trial information about Travere products and related information. The information provided is intended for US healthcare professionals only to answer unsolicited medical questions, but it is not intended to provide medical advice.See details»

Travere Therapeutics - Crunchbase Company Profile & Funding

Aug 16, 2013 Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.See details»

Travere Therapeutics Overview | SignalHire Company Profile

The annual revenue of Travere Therapeutics varies between 100M and 500M. Total funding of the company - $68.9M. To connect with Travere Therapeutics employee register on SignalHire. Organization Website travere.com Social Links Phone Number 8889697879 Travere Therapeutics industries Biotech, Pharmaceuticals, Biotechnology Headquarters LocationSee details»

Leadership & Board | Travere

Board Diversity Travere is committed to the principles of workforce development, diversity and inclusion adopted by the Biotechnology Innovation Organization. Learn more about our DEI commitment.See details»

Travere Therapeutics - Profiles & Contacts - Crunchbase

Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.See details»

Member Spotlight: Travere Therapeutics - Biocom California

June 15, 2023 Member Spotlight: Travere Therapeutics Travere Therapeutics Advocates for Patients and Health Equity While Finding Treatments for Rare Diseases Eric Dube is no stranger to overcoming adversity. When he was 18 years old in the early โ€˜90s, he came out as a gay manโ€”at a time when the HIV epidemic was at its height.See details»

Contact - Travere Medical Affairs

The purpose of this Travere Therapeutics Medical Affairs website is to support healthcare professionals with scientific information. This website is also a channel for US healthcare professionals to submit questions or connect with Travere Therapeutics US โ€ฆSee details»

Travere Therapeutics: Culture | LinkedIn

Travere Therapeutics provides competitive benefits and a highly collaborative hybrid working environment (Flex Forward) that values equity, diversity and inclusion.See details»

Travere Therapeutics - Governance - Governance Documents

News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & PresentationsSee details»

Careers - travere.wd1.myworkdayjobs.com

Travere provides comprehensive total rewards offerings that demonstrate our commitment as a diverse, equitable, people-centric, and pay-for-performance organization.See details»

linkstock.net © 2022. All rights reserved